Kyle A. Furge

5.5k total citations
55 papers, 3.8k citations indexed

About

Kyle A. Furge is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Kyle A. Furge has authored 55 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 23 papers in Pulmonary and Respiratory Medicine and 20 papers in Cancer Research. Recurrent topics in Kyle A. Furge's work include Renal cell carcinoma treatment (20 papers), Renal and related cancers (14 papers) and Cancer Genomics and Diagnostics (13 papers). Kyle A. Furge is often cited by papers focused on Renal cell carcinoma treatment (20 papers), Renal and related cancers (14 papers) and Cancer Genomics and Diagnostics (13 papers). Kyle A. Furge collaborates with scholars based in United States, Singapore and Canada. Kyle A. Furge's co-authors include Bin Tean Teh, George F. Vande Woude, Karl Dykema, Richard J. Kahnoski, David Petillo, Ximing J. Yang, Charles F. Albright, Masayuki Takahashi, Susumu Kagawa and Hiro‐omi Kanayama and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Kyle A. Furge

55 papers receiving 3.7k citations

Peers

Kyle A. Furge
Adrian M. Jubb United Kingdom
Caterina Nardella United States
Igor Garkavtsev United States
Ying‐Bei Chen United States
Kyle A. Furge
Citations per year, relative to Kyle A. Furge Kyle A. Furge (= 1×) peers Tokuzo Arao

Countries citing papers authored by Kyle A. Furge

Since Specialization
Citations

This map shows the geographic impact of Kyle A. Furge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle A. Furge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle A. Furge more than expected).

Fields of papers citing papers by Kyle A. Furge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle A. Furge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle A. Furge. The network helps show where Kyle A. Furge may publish in the future.

Co-authorship network of co-authors of Kyle A. Furge

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle A. Furge. A scholar is included among the top collaborators of Kyle A. Furge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle A. Furge. Kyle A. Furge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Furge, Kyle A., et al.. (2020). Tryptophan-75 Is a Low-Energy Channel-Gating Residue that Facilitates Substrate Egress/Access in Cytochrome P450 2D6. Drug Metabolism and Disposition. 49(3). 179–187. 2 indexed citations
2.
Nickoloff, Brian J., Karl Dykema, Elissa A. Boguslawski, et al.. (2013). Pharmacologic Inhibition of MEK Signaling Prevents Growth of Canine Hemangiosarcoma. Molecular Cancer Therapeutics. 12(9). 1701–1714. 21 indexed citations
3.
Ooi, Aikseng, Karl Dykema, Asif Ansari, et al.. (2013). CUL3 and NRF2 Mutations Confer an NRF2 Activation Phenotype in a Sporadic Form of Papillary Renal Cell Carcinoma. Cancer Research. 73(7). 2044–2051. 121 indexed citations
4.
Wondergem, Bill, Zhongfa Zhang, Dachuan Huang, et al.. (2012). Expression of the PTTG1 Oncogene Is Associated with Aggressive Clear Cell Renal Cell Carcinoma. Cancer Research. 72(17). 4361–4371. 45 indexed citations
5.
Zhang, Yuwen, Ben Staal, Karl Dykema, Kyle A. Furge, & George F. Vande Woude. (2012). Cancer-Type Regulation of MIG-6 Expression by Inhibitors of Methylation and Histone Deacetylation. PLoS ONE. 7(6). e38955–e38955. 16 indexed citations
6.
Ding, Yan, Dan Huang, Zhongfa Zhang, et al.. (2011). Combined Gene Expression Profiling and RNAi Screening in Clear Cell Renal Cell Carcinoma Identify PLK1 and Other Therapeutic Kinase Targets. Cancer Research. 71(15). 5225–5234. 31 indexed citations
7.
Roos, Frederik C., Andrew Evans, Walburgis Brenner, et al.. (2011). Deregulation of E2-EPF Ubiquitin Carrier Protein in Papillary Renal Cell Carcinoma. American Journal Of Pathology. 178(2). 853–860. 35 indexed citations
8.
Huang, Dan, Yan Ding, Ming Zhou, et al.. (2010). Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma. Cancer Research. 70(3). 1063–1071. 330 indexed citations
9.
Zang, Zhi Jiang, Choon Kiat Ong, Ioana Cutcutache, et al.. (2010). Genetic and Structural Variation in the Gastric Cancer Kinome Revealed through Targeted Deep Sequencing. Cancer Research. 71(1). 29–39. 69 indexed citations
10.
Lindvall, Charlotta, Cassandra R. Zylstra, Nicole C. Evans, et al.. (2009). The Wnt Co-Receptor Lrp6 Is Required for Normal Mouse Mammary Gland Development. PLoS ONE. 4(6). e5813–e5813. 115 indexed citations
11.
Roche, O., Greg Finak, Andrew Evans, et al.. (2009). Regulation of endocytosis via the oxygen-sensing pathway. Nature Medicine. 15(3). 319–324. 160 indexed citations
12.
Koeman, Julie, Ryan C. Russell, Min‐Han Tan, et al.. (2008). Correction: Somatic Pairing of Chromosome 19 in Renal Oncocytoma Is Associated with Deregulated EGLN2-Mediated Oxygen-Sensing Response. PLoS Genetics. 4(9). 3 indexed citations
13.
Furge, Kyle A., Jindong Chen, Julie Koeman, et al.. (2007). Detection of DNA Copy Number Changes and Oncogenic Signaling Abnormalities from Gene Expression Data Reveals MYC Activation in High-Grade Papillary Renal Cell Carcinoma. Cancer Research. 67(7). 3171–3176. 112 indexed citations
14.
Furge, Kyle A., Karl Dykema, Eric J. Kort, et al.. (2007). Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling. Oncogene. 26(9). 1346–1350. 35 indexed citations
15.
Furge, Kyle A., Eric J. Kort, Ximing J. Yang, et al.. (2006). Gene Expression Profiling in Kidney Cancer: Combining Differential Expression and Chromosomal and Pathway Analyses. Clinical Genitourinary Cancer. 5(3). 227–231. 3 indexed citations
16.
Patil, Mohini A., Ines Gütgemann, Ji Zhang, et al.. (2005). Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis. 26(12). 2050–2057. 111 indexed citations
18.
Furge, Kyle A., Masayuki Takahashi, Jun Sugimura, et al.. (2004). Robust Classification of Renal Cell Carcinoma Based on Gene Expression Data and Predicted Cytogenetic Profiles. Cancer Research. 64(12). 4117–4121. 82 indexed citations
19.
Dykema, Karl & Kyle A. Furge. (2004). Diminished transcription of chromosome arm 4q is inversely related to local spreading of hepatocellular carcinoma. Genes Chromosomes and Cancer. 41(4). 390–394. 5 indexed citations
20.
Mach, Kathleen E., Kyle A. Furge, & Charles F. Albright. (2000). Loss of Rhb1, a Rheb-Related GTPase in Fission Yeast, Causes Growth Arrest With a Terminal Phenotype Similar to That Caused by Nitrogen Starvation. Genetics. 155(2). 611–622. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026